Trial Profile
A Randomized Phase I/II Study to Assess the Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-Level Deep Venous Thrombosis
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 17 Jun 2019
Price :
$35
*
At a glance
- Drugs Uproleselan (Primary) ; Enoxaparin sodium
- Indications Deep vein thrombosis
- Focus Adverse reactions
- Sponsors GlycoMimetics
- 12 Jun 2019 Status changed from completed to discontinued.
- 24 Apr 2017 Status changed from recruiting to completed.
- 08 Jul 2016 Status changed from not yet recruiting to recruiting.